Valproate (Valproic acid) can cause developmental toxicity according to an independent committee of scientific and health experts.
Definition
Valproate (Valproic acid) can cause developmental toxicity according to an independent committee of scientific and health experts.
Source: PubChem
US FDA substance register · UNII 614OI1Z5WI · registered name Valproic acid · single chemical substance
Cosmetic roles
Safety & regulatory references
Not classified under Korea’s toxic-substance GHS list · existing chemical substance
More data — names, identifiers, properties, test records, literature
Names & identifiers
- CAS No.chemical registry number
- 99-66-1
- EC No.EU chemical inventory number
- 202-777-3
- DTXSIDUS EPA chemical ID
- DTXSID6023733
- DTXCIDUS EPA compound ID
- DTXCID803733
- IUPAC
- 2-Propylpentanoic acid
- Molecular formula
- C8H16O2
- Molecular weight
- 144.214 g/mol
Measured properties
- Appearance
- Valproic acid is a clear colorless liquid. (NTP, 1992) · Liquid
- Odour
- Characteristic odor
- Boiling point
- 428 °F at 760 mmHg (NTP, 1992) · 222
- Solubility
- less than 1 mg/mL at 72 °F (NTP, 1992) · 1.3 mg/mL
- Density
- 0.922 at 32 °F (NTP, 1992) - Less dense than water, will float · 0.904 g/cu cm at 25 °C
- Dissociation constant
- 4.8 · pKa = 4.6
- Colour
- colourless
- Initial boiling point and range
- 219.5 ℃
- Flash point
- 111 ℃
- Water solubility
- 2000 ㎎/ℓ (20℃)
- Relative density
- 0.904 (25 ℃ / 4℃)
- n-Octanol/water partition coefficient (Kow)
- 2.75 (exp)
- Molecular weight
- 144.21
Values measured on the substance itself. The KOSHA data are a reference for writing and reviewing safety data sheets, not a specification for a commercial raw material.
Source: PubChem · KOSHA safety data sheets (Korea)
What products actually use it for
What the 2 products reported to the US EPA with this ingredient use it for. Products outside cosmetics are included, so the top few rows are its main uses.
- Pharmaceutical (EPA)1
- Softener and conditioner1
Source: US EPA CompTox dashboard
Irritation and sensitisation studies
4 skin studies and 2 eye studies are on record.
The study conclusions largely agree (100%). These tests are on the raw material itself; irritation at the amount in a finished product is a different question.
See all 6 studies
- Category 6.3A (Category 2)
Skin Irritation · Read Across - Classification not possible
Skin Sensitization · Screening - Classification not possible
Skin Irritation · Screening - Not likely to be sensitizing
skin sensitisation: in vivo (LLNA) · Screening · equivalent or similar to OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay) - Classification not possible
Eye Irritation · Screening - Category 6.4A (Category 2A)
Eye Irritation · Read Across
Source: US EPA CompTox dashboard
Related literature
- Association of ABCB1 Polymorphisms with Efficacy and Adverse Drug Reactions of Valproic Acid in Children with Epilepsy · 2023
- Valproic acid-induced DRESS confirmed by positive patch test · 2020
- Induction of Glycosphingolipid GM3 Expression by Valproic Acid Suppresses Cancer Cell Growth* · 2016
- Valproic acid sensitizes human glioma cells to gefitinib‐induced autophagy · 2015
- Stevens–Johnson syndrome induced by a combination of lamotrigine and valproic acid · 2015
Linked databases 16
- Australian Industrial Chemicals Inventory (AICIS)
- ChEBI
- ChEMBL
- EU CosIng ingredient list 2
- Korea toxic substances GHS register (NIER)
- KOSHA safety data sheets (Korea)
- NIST Chemistry WebBook
- PubChem 2
- Tlooto literature search 2 3 4 5
- UniChem cross-reference IDs
- US EPA CompTox dashboard 2
- US EPA DSSTox chemical database
- US FDA substance registration (GSRS)
- US FDA Unique Ingredient Identifier (UNII)
- Wikidata
- Wikipedia · Korean · English · Japanese · Chinese